These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9346708)

  • 1. Prevention of infection in the liver transplant recipient.
    Rubin RH
    Liver Transpl Surg; 1996 Sep; 2(5 Suppl 1):89-98. PubMed ID: 9346708
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pre-transplant evaluation of the donor and recipient. Recommendations for surveillance and control of infection after transplantation].
    Cisneros JM; Cañas E; Pachón J
    Enferm Infecc Microbiol Clin; 1997 May; 15 Suppl 2():98-103. PubMed ID: 9312304
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.
    Burak KW; Kremers WK; Batts KP; Wiesner RH; Rosen CB; Razonable RR; Paya CV; Charlton MR
    Liver Transpl; 2002 Apr; 8(4):362-9. PubMed ID: 11965581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytomegalovirus infection in lung transplantation; current status, detection, prophylactic treatment].
    Aoe M; Tao H; Yamane M; Toyooka S; Sano Y; Okazaki M; Date H
    Kyobu Geka; 2007 Oct; 60(11):988-92. PubMed ID: 17926902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation.
    Hellinger WC; Bonatti H; Yao JD; Alvarez S; Brumble LM; Keating MR; Mendez JC; Kramer DJ; Dickson RC; Harnois DM; Spivey JR; Hughes CB; Nguyen JH; Steers JL
    Liver Transpl; 2005 Jun; 11(6):656-62. PubMed ID: 15915482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factors and chronology of infection in solid organ transplantation].
    Gavaldà J; Pahissa A
    Enferm Infecc Microbiol Clin; 1997 May; 15 Suppl 2():3-11. PubMed ID: 9312297
    [No Abstract]   [Full Text] [Related]  

  • 7. Suspect the donor with potential infection in the adult deceased donor liver transplantation.
    Wu TJ; Lee CF; Chou HS; Yu MC; Lee WC
    Transplant Proc; 2008 Oct; 40(8):2486-8. PubMed ID: 18929774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for cytomegalovirus infection after orthotopic liver transplantation using an ultrasensitive polymerase chain reaction assay.
    Basse G; Esposito L; Mengelle C; Kamar N; Ribes D; Lavayssière L; Pillet A; Suc B; Barange K; Rostaing L
    Transplant Proc; 2006 Sep; 38(7):2339-41. PubMed ID: 16980084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated.
    Yokoe D; Casper C; Dubberke E; Lee G; Muñoz P; Palmore T; Sepkowitz K; Young JA; Donnelly JP; ; ; ; ; ; ; ; ;
    Bone Marrow Transplant; 2009 Oct; 44(8):495-507. PubMed ID: 19861984
    [No Abstract]   [Full Text] [Related]  

  • 10. Introduction to the Immunocompromised Host Society consensus conference on epidemiology, prevention, diagnosis, and management of infections in solid-organ transplant patients.
    Rubin RH; Schaffner A; Speich R
    Clin Infect Dis; 2001 Jul; 33 Suppl 1():S1-4. PubMed ID: 11389514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N; Holman MJ; Yang HC
    Clin Transplant; 1997 Dec; 11(6):633-9. PubMed ID: 9408699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive zygomycosis in transplant recipients.
    Uçkay I; Chalandon Y; Sartoretti P; Rohner P; Berney T; Hadaya K; van Delden C
    Clin Transplant; 2007; 21(4):577-82. PubMed ID: 17645724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir.
    Palmer SM; Grinnan DC; Diane Reams B; Steele MP; Messier RH; Duane Davis R
    Clin Transplant; 2004 Apr; 18(2):179-85. PubMed ID: 15016133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiology and prevention of donor-derived infections.
    Ison MG
    Adv Chronic Kidney Dis; 2009 Jul; 16(4):234-41. PubMed ID: 19576553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus in liver transplant recipients: there are many ways to Rome.
    Rayes N; Seehofer D; Neuhaus P
    Liver Transpl; 2006 Feb; 12(2):326. PubMed ID: 16447200
    [No Abstract]   [Full Text] [Related]  

  • 16. Bacterial- and fungal-positive cultures in organ donors: clinical impact in liver transplantation.
    Cerutti E; Stratta C; Romagnoli R; Serra R; Lepore M; Fop F; Mascia L; Lupo F; Franchello A; Panio A; Salizzoni M
    Liver Transpl; 2006 Aug; 12(8):1253-9. PubMed ID: 16724336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver allograft pathology.
    Hart J; Lewin KJ
    Pathology (Phila); 1994; 3(1):207-50. PubMed ID: 9420899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Infections in solid organ transplant recipients].
    Cuellar-Rodríguez J; Sierra-Madero JG
    Rev Invest Clin; 2005; 57(2):368-80. PubMed ID: 16524080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and diagnosis of active toxoplasma infection among liver transplant recipients in Western Turkey.
    Caner A; Döşkaya M; Karasu Z; Değirmenci A; Guy E; Kiliç M; Zeytunlu M; Francis J; Bozoklar A; Gürüz Y
    Liver Transpl; 2008 Oct; 14(10):1526-32. PubMed ID: 18825713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunizations and infectious diseases in pediatric liver transplantation.
    Halasa N; Green M
    Liver Transpl; 2008 Oct; 14(10):1389-99. PubMed ID: 18825728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.